From Medscape Neurology

Coverage from the

American Academy of Neurology (AAN) 2024 Annual Meeting

April 13 - 18, 2024; Denver, Colorado

April 13 - 18, 2024 Denver, Colorado

Conference News

AAN 2024 New Clinical Guidance for Sjögren-Related Neuropathy
Medscape Medical News, May 8, 2024
AAN 2024 Major Gaps in Care, Management of Neurologic Diseases
Medscape Medical News, May 1, 2024
AAN 2024 Prominent ALS Researcher Moves From Treatment to Prevention
MDedge News, April 26, 2024
AAN 2024 How Do Newer Antidiabetic Drugs Lower Stroke Risk?
MDedge News, April 26, 2024
AAN 2024 Lecanemab Extension Study for AD Offers Mixed Results
MDedge News, April 26, 2024
AAN 2024 Could Bedside Training Help End the US Neurologist Shortage?
Medscape Medical News, April 26, 2024
AAN 2024 Exposure to Industrial Solvent Linked to 24% Higher PD Risk
MDedge News, April 26, 2024
AAN 2024 Largest CIDP Trial Offers Promising Results for Drug Combo
MDedge News, April 25, 2024
AAN 2024 Teleneurology for Suspected Stroke Speeds Treatment
Medscape Medical News, April 24, 2024
AAN 2024 Novel Agent Curbs Alzheimer's-Related Agitation
Medscape Medical News, April 23, 2024
AAN 2024 ICI Tx in MS Patients With Comorbid Cancer: Reassuring Data
Medscape Medical News, April 19, 2024
AAN 2024 Lidocaine Nerve Block Effective for Severe Migraine in Kids
Medscape Medical News, April 19, 2024

AAN 2024 New and Improved Option for Detecting Neurologic Pathogens?
Medscape Medical News, April 17, 2024
AAN 2024 Vaporized Cannabis for Acute Migraine Yields Rapid Relief
Medscape Medical News, April 17, 2024
AAN 2024 Tension, Other Headache Types Robustly Linked to Suicide
Medscape Medical News, April 16, 2024
$IV Ketamine Promising for Refractory Headache in Kids$ AAN 2024 IV Ketamine Promising for Refractory Headache in Kids
Medscape Medical News, April 16, 2024
AAN 2024 First Long-Term Data on Atogepant for Migraine Prevention
Medscape Medical News, April 16, 2024
AAN 2024 'Compelling' Results for AI EEG to Predict Outcomes
Medscape Medical News, April 15, 2024
AAN 2024 ET Tied to a Threefold Increased Risk for Dementia
Medscape Medical News, March 13, 2024
AAN 2024 Infant Exposure to MS Drugs via Breastfeeding: New Data
Medscape Medical News, March 12, 2024
AAN 2024 Most Disadvantaged Least Likely to Receive Thrombolysis
Medscape Medical News, March 8, 2024
AAN 2024 Sleep Apnea Hard on the Brain
Medscape Medical News, March 6, 2024
AAN 2024 A New Biomarker of Brain Injury?
Medscape Medical News, March 5, 2024

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Multiple Sclerosis Highlights From AAN 2024
Pavan Bhargava, MD

Popular News From AAN 2023

Direct Comparison of 25 Migraine Meds Reveals Top Options A large, real-world data analysis of 3 million migraine attacks shows triptans, ergots, and antiemetics are the most effective classes of medications.
Medscape Medical News, May 02, 2023
Even Mild COVID Is Hard on the Brain New research reveals structural and functional changes in the brain associated with anxiety and depression after mild COVID-19 infection.
Medscape Medical News, Mar 06, 2023
Mississippi–Ohio River Valley Linked to Higher Risk of Parkinson's Evidence is mounting that 'air pollution may be an important causal factor in Parkinson's and especially Alzheimer's disease.
Medscape Medical News, Apr 12, 2023

Previous Coverage

Related Resources